Document is current
Any future updates will be listed below
-
Authors
El-Abiary, Mariam https://orcid.org/0000-0003-0870-8874
Yorston, David
Laidlaw, D Alistair H
Williamson, Tom
Steel, David H.
,
Goldsmith, Craig
Rowley, Steven
Wnder, Stephen
Cornish, Kurt Spiteri
Masri, Ibrahim
Smith, Jonathan
Sanchez-Chicharro, Diego
Babar, Atiq
Balaggan, Kamaljit Singh
Figueroa, Marta
Gonzalez-Lopez, Julio J.
Herbert, Edward
Membrey, William Luke
Cochrane, Timothy
Mitrut, Izabela
Wakely, Laura
Papastavrou, Vasileios
Crosby, Niall
Forsaa, Vegard
Vayalambrone, Deepak
Hillier, Roxane
Di Simplicio Cherubini, Sandro
Jalil, Assad
Charles, Stephen J.
Ivanova, Tsveta
Ellabban, Abdallah A.
Chandra, Aman
Khan, Imran J.
Chua, Paul Y.
Tan, Shi Z.
Hussain, Rumana N.
Heimann, Heinrich
Pearce, Ian A.
Sandinha, Teresa
Groenewald, Carl
Jmor, Fidan
Le Mer, Yannick
Casswell, Edward J.
Casswell, Tony
Tanner, Vaughan
Meireles, Angelina
Crama, Niels
Ellis, John
Tarafdar, Sonali
Jenkins, Huw
Davies, Andrew
- License Information
-
More Information
Article History
Received: 30 April 2025
Revised: 12 November 2025
Accepted: 17 December 2025
First Online: 22 January 2026
Declarations
:
: This article does not contain any studies with human participants performed by any of the authors.
: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. DAHL : General disclosure includes Owner of COMPlog Visual Acuity Measurement Systems Ltd. DS : General disclosures include consultancy in the last two years with Alcon, BVI, DORC, Roche, Alimera, Eyepoint, Complement Therapeutics, Sitala, AviadoBio, VascVersa. Research Funding to institute: Alcon, Bayer, Roche, DORC, BVI, Boehringer.
